68 New COVID-19 Cases Since Tuesday’s Report
& 1 Death Reported
51,019 Total Positive Cases & 1,181 Total Deaths
MOHAVE COUNTY, AZ (February 24, 2022) — The Mohave County Health Department (MCDPH) Nursing staff has been notified of 68 new confirmed COVID-19 cases reported since Tuesday at noon. There is also 1 newly reported death.
The solo death is a previously reported positive case, a 50-59 person in the Bullhead City service area.
ALL 68 new confirmed positive cases remain under investigation.
Of the 68 new confirmed cases, there are 20 confirmed cases in the Bullhead City service area. There are 23 new confirmed cases in the Kingman service area. There are 18 new confirmed cases in the Lake Havasu City service area. There are 6 new confirmed case in the North County service area. There is 1 new confirmed case in an Unknown area of the county.
Of the 20 new confirmed cases in the Bullhead City area, 2 are 0-10; 1 is 11-19; 4 are 20-29; 8 are 30-39; 1 is 40-49; 2 are 50-59; 2 are 60-69.
Of the 23 new confirmed cases in the Kingman area, 3 are 0-10; 1 is 11-19; 5 are 20-29; 3 are 30-39; 3 are 40-49; 3 are 50-59; 2 are 60-69; 2 are 70-79; 1 is 80-89.
Of the 18 new confirmed cases in the Lake Havasu City area, 2 are 0-10; 1 is 11-19; 2 are 20-29; 2 are 40-49; 6 are 50-59; 4 are 60-69; 1 is 70-79.
Of the 6 new confirmed cases in the North County area, 1 is 0-10; 1 is 20-29; 2 are 30-39; 1 is 60-69; 1 is 70-79.
The singular new confirmed case in an Unknown/Undermined area of the county is a 30-39 person.
TOTAL RECOVERED THUS FAR: 36,513
AVERAGE AGE OF CASES SINCE CASE #1: 44.7
AVERAGE AGE OF DEATHS SINCE FIRST DEATH: 72.0
In the United States, CDC uses genomic surveillance to track variants of SARS-CoV-2, the virus that causes COVID-19, to more quickly identify and act upon these findings to best protect the public’s health. CDC reports that if a variant is circulating at 0.1% frequency, there is a 99% chance it will be detected in CDC’s national genomic surveillance.
CDC scientists will continue working with partners to gather data and virus samples that can be studied to answer essential questions and inform public health practice regarding the Omicron variant as it spreads in the U.S. and other parts of the world.
The Omicron variant likely will spread more easily than the original SARS-CoV-2 virus. CDC expects that anyone with Omicron infection can spread the virus to others, even if they are vaccinated or don’t have symptoms. More data is needed to know if Omicron infections, reinfections, and breakthrough infections in fully vaccinated people cause more severe illness or death than infection with other variants. The CDC says COVID-19 vaccines remain the best public health measure to protect people from severe illness, slow transmission of the virus, and reduce the likelihood of new variants emerging.
Protect yourself and others
- Get Vaccinated
- Wear a mask in areas of substantial or high transmission
- Stay 6 feet away from others
- Avoid crowds and poorly ventilated spaces
- Wash your hands often
- Clean and disinfect high touch surfaces
- Cover coughs and sneezes
- Test to prevent the spread to others
- Monitor your health daily – Be alert for symptoms
For more detailed information, please visit https://www.cdc.gov/coronavirus/2019-ncov/prevent-getting-sick/prevention.html
ADHS has launched a new website for treatments in Arizona to complement the current monoclonal antibodies website.
While vaccines provide the best protection from COVID-19, treatment options such as Monoclonal Antibody therapy can shorten the duration of symptoms and reduce the risk of severe illness and hospitalization.
Monoclonal antibodies, or mAbs, are made in a laboratory to fight a particular infection — in this case, the virus that causes COVID-19 — and are given to patients directly with an infusion or a shot. Your body naturally makes antibodies to fight infection. However, your body may not have antibodies designed to recognize a new virus-like the virus that causes COVID-19. That’s why mAb treatment may help patients at high risk for severe symptoms or hospitalization.
The Food and Drug Administration (FDA) has issued an Emergency Use Authorization (EUA) to allow the use of monoclonal antibody therapies for the treatment of mild to moderate COVID19 in certain high-risk patients. Some people who have been exposed to COVID-19 may qualify for treatment even before testing positive for COVID-19. This treatment is not a substitute for vaccination against COVID-19.
General eligibility information is below.
- Individuals who have tested positive for COVID-19 and are within ten days of onset
- Unvaccinated individuals who have had close contact with a COVID positive person
- Vaccinated individuals who are immunocompromised and have had close contact with a COVID-positive person
- Each facility has its standards for administering Monoclonal Antibody Therapy. Please visit their respective websites or call the number provided below for more information.
Kingman Regional Medical Center (KRMC)
Phone Number: 928-681-8699
Western Arizona Regional Medical Center (WARMC)
Phone number: 928-763- 2273
Havasu Urgent Care (aka Havasu Primary Care and Pediatrics)
Phone number: 928-505-1030
Veklury® (Remdesivir) (FDA approved)
Veklury® (Remdesivir) works by slowing the replication of the COVID-19 virus, thereby reducing the amount of virus circulating in the body. Veklury® (Remdesivir) is approved for hospitalized patients age 12 years and older who weigh at least 88 pounds, with more severe COVID-19 disease. Your hospital care team will decide if you are eligible to receive this treatment.
Additional COVID-19 Questions?, Please Call 928-753-8665